New Drug Formulations – For Patients or Profits? Wang et al in JAMA Network Research Letter, reviewed Medicaid expenditures on ADA, noted that the introduction of the citrate-free formulation cost an extra $4.4B to Medicaid from 2014-2021. https://t.co/W1sst12GJK https://t.co/OYLkSHEQ2X